Hudson Bay Capital Management »

Cytokinetics shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $17M 248k 70.11
2023-09-30 $2.4M 80k 29.46
2023-06-30 $652k 20k 32.62
2020-06-30 $1.2M 50k 23.56
2020-03-31 $2.1M 175k 11.79
2019-12-31 $2.4M 225k 10.61

More positions owned by Hudson Bay Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Microsoft Corporation Put Option (MSFT)
NVIDIA Corporation Call Option (NVDA)
Amazon Call Option (AMZN)
Apple Put Option (AAPL)
Alphabet Cap Stk Cl C Put Option (GOOG)
Meta Platforms Cl A Put Option (META)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Put Option (TSLA)
Advanced Micro Devices Put Option (AMD)
Ishares Tr Msci Acwi Etf Put Option (ACWI)
Berkshire Hathaway Inc Del Cl B New Put Option (BRK.B)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Pioneer Natural Resources Put Option (PXD)
Royal Caribbean Group Note 6.000% 8/1 (Principal)

View all positions for Hudson Bay Capital Management

Top funds holding Cytokinetics

BlackRock
FMR
Vanguard Group
Wellington Management Company
Bank of America Corporation
T. Rowe Price Investment Management
T. Rowe Price Associates
Marshall Wace
Pentwater Capital Management
Geode Capital Management
Armistice Capital
HAP Trading
Susquehanna International
Boxer Capital
Melqart Asset Management

View all funds holding Cytokinetics